In addition, near the tumor invasive front, relative high levels of CD163+ were detected in LN metastatic Kras patients in advanced stage (Stage III–IV) compared to chemonaive-responding to chemotherapy regimen-early stage individuals, indicating a CD163+/M2 macrophage involvement in tumor propagation (Fig. 1B). Here, CD163 is linked to neoplasm.